مقالات بحثية تمّ التفويض بإتاحتها للجميع - Hideho Okadaمزيد من المعلومات
عدد المقالات البحثية غير المتاحة للجميع في أي موقع: 4
مراجعة
Actively personalized vaccination trial for newly diagnosed glioblastoma‏
N Hilf, S Kuttruff-Coqui, K Frenzel, V Bukur, S Stevanović, ...‏
Nature 565 (7738), 240-245, 2019‏
التفويضات: Cancer Research UK, UK Medical Research Council‏
مراجعة
Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development‏
G Kohanbash, H Okada‏
Immunological investigations 41 (6-7), 658-679, 2012‏
التفويضات: US National Institutes of Health‏
مراجعة
The role of emerging therapy in the management of patients with diffuse low grade glioma‏
AE Sloan, H Okada, TC Ryken, SN Kalkanis, JJ Olson‏
Journal of neuro-oncology 125, 631-635, 2015‏
التفويضات: US National Institutes of Health‏
مراجعة
Peptide vaccine therapy for childhood gliomas‏
IF Pollack, RI Jakacki, LH Butterfield, H Okada‏
Neurosurgery 60, 113-119, 2013‏
التفويضات: US National Institutes of Health‏
عدد المقالات البحثية المتاحة للجميع في موقع ما: 123
مراجعة
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma‏
DM O’Rourke, MLP Nasrallah, A Desai, JJ Melenhorst, K Mansfield, ...‏
Science translational medicine 9 (399), eaaa0984, 2017‏
التفويضات: US National Institutes of Health‏
مراجعة
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group‏
H Okada, M Weller, R Huang, G Finocchiaro, MR Gilbert, W Wick, ...‏
The Lancet Oncology 16 (15), e534-e542, 2015‏
التفويضات: US National Institutes of Health, Wellcome Trust‏
مراجعة
Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic …‏
H Okada, P Kalinski, R Ueda, A Hoji, G Kohanbash, TE Donegan, ...‏
Journal of clinical oncology 29 (3), 330-336, 2011‏
التفويضات: US National Institutes of Health‏
مراجعة
Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment‏
S Müller, G Kohanbash, SJ Liu, B Alvarado, D Carrera, A Bhaduri, ...‏
Genome biology 18, 1-14, 2017‏
التفويضات: US National Institutes of Health‏
مراجعة
Classification of current anticancer immunotherapies‏
L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqué, L Senovilla, ...‏
Oncotarget 5 (24), 12472, 2014‏
التفويضات: US National Institutes of Health, National Health and Medical Research …‏
مراجعة
Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma‏
LA Johnson, J Scholler, T Ohkuri, A Kosaka, PR Patel, SE McGettigan, ...‏
Science translational medicine 7 (275), 275ra22-275ra22, 2015‏
التفويضات: US National Institutes of Health‏
مراجعة
COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells‏
M Fujita, G Kohanbash, W Fellows-Mayle, RL Hamilton, Y Komohara, ...‏
Cancer research 71 (7), 2664-2674, 2011‏
التفويضات: US National Institutes of Health‏
مراجعة
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas‏
G Kohanbash, DA Carrera, S Shrivastav, BJ Ahn, N Jahan, T Mazor, ...‏
The Journal of clinical investigation 127 (4), 1425-1437, 2017‏
التفويضات: US National Institutes of Health‏
مراجعة
SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma‏
JH Choe, PB Watchmaker, MS Simic, RD Gilbert, AW Li, NA Krasnow, ...‏
Science translational medicine 13 (591), eabe7378, 2021‏
التفويضات: US National Institutes of Health, Howard Hughes Medical Institute‏
مراجعة
STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment‏
T Ohkuri, A Ghosh, A Kosaka, J Zhu, M Ikeura, M David, SC Watkins, ...‏
Cancer immunology research 2 (12), 1199-1208, 2014‏
التفويضات: US National Institutes of Health‏
مراجعة
Novel and shared neoantigen derived from histone 3 variant H3. 3K27M mutation for glioma T cell therapy‏
ZS Chheda, G Kohanbash, K Okada, N Jahan, J Sidney, M Pecoraro, ...‏
Journal of Experimental Medicine 215 (1), 141-157, 2018‏
التفويضات: US National Institutes of Health, Government of Spain, V Foundation, USA‏
مراجعة
Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and …‏
IF Pollack, RI Jakacki, LH Butterfield, RL Hamilton, A Panigrahy, ...‏
Journal of Clinical Oncology 32 (19), 2050-2058, 2014‏
التفويضات: US National Institutes of Health‏
مراجعة
GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-α‏
G Kohanbash, K McKaveney, M Sakaki, R Ueda, AH Mintz, N Amankulor, ...‏
Cancer research 73 (21), 6413-6423, 2013‏
التفويضات: US National Institutes of Health‏
مراجعة
Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1‏
R Ueda, G Kohanbash, K Sasaki, M Fujita, X Zhu, ER Kastenhuber, ...‏
Proceedings of the National Academy of Sciences 106 (26), 10746-10751, 2009‏
التفويضات: US National Institutes of Health‏
مراجعة
Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy‏
X Zhu, M Fujita, LA Snyder, H Okada‏
Journal of neuro-oncology 104, 83-92, 2011‏
التفويضات: US National Institutes of Health‏
مراجعة
Immunotherapeutic approaches for glioma‏
H Okada, G Kohanbash, X Zhu, ER Kastenhuber, A Hoji, R Ueda, M Fujita‏
Critical Reviews™ in Immunology 29 (1), 2009‏
التفويضات: US National Institutes of Health‏
يتم تحديد معلومات التمويل والنشر من خلال برنامج كمبيوتر تلقائيًا.